12:00 AM
Dec 17, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Karyopharm preclinical data

In an animal model of SLE, oral selective inhibitor of nuclear export (SINE) protein exportin 1 ( XPO1; CRM1) antagonists reduced...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >